Previous Page  8 / 11 Next Page
Information
Show Menu
Previous Page 8 / 11 Next Page
Page Background

PCOS 2018

Journal of Clinical and Molecular Endocrinology

ISSN: 2572-5432

Page 24

June 07-08, 2018

London, UK

4

th

World Congress on

Polycystic Ovarian

Syndrome

A

ndrogen excess is generally considered as one of the major

characteristics of polycystic ovarian syndrome (PCOS).

Evidence from clinical research has revealed increased levels

of oxidative stress (OS) in PCOS patients. Recent research

showed that androgen induced PCOS rat existed over fibrosis,

whichmay have influence on ovary function. Our study aimed to

investigate the possible inhibition of hyperandrogenic ovarian

fibrosis by preventing p66shc-induced oxidative stress. Our

data demonstrated that inhibiting the expression of p66shc

could suppress ovarian oxidative stress, thereby restraining

further fibrosis. In ovarian tissues, reduced fibrosis together

with lowered expression of p66shc and ROS was observed

in resveratrol- and metformin-treated rats. Down-regulation

of fibrogenic factors including collagens, TGF-β, CTGF,

β-catenin and α-SMA as a result of the inhibition of p66shc

was confirmed by western blot, Q-PCR, immunofluorescence

and immunohistochemistry. We also observed that p66shc

was mainly expressed in the nuclei of granulosa cells (GC)

and theca cells (TC). Knockdown of p66shc resulted in

dramatic down-regulation of ROS and fibrogenic factors such

as TGF-β, CTGF, β-catenin and α-SMA in ovarian granulosa

cells and theca cells. Furthermore, inhibition of fibrosis was

accompanied with markedly improved ovarian morphology,

increased luteal cell number and lowered levels of androgen.

These findings suggest that p66shc may be a direct target

of SIRT1 for inducing ROS and thus promoting fibrosis. We

believe that further exploration of the mechanisms of p66shc

in both fibrosis and oxidative stress may provide therapeutic

strategies in improving PCOS symptoms and reproductive

function.

Biography

Yong Wang is a Professor at Medical School, Nanjing University, China

whose research interest focuses on Polycystic Ovary Syndrome. He is dedi-

cated to the teaching of Histology and Embryology.

yongwang@nju.edu.cn

The critical role of p66shc oxidative stress pathway in

hyperandrogen-induced ovarian fibrosis

Yong Wang

and

Daojuan Wang

Nanjing University, China

Yong Wang et al., J Clin Mol Endocrinol 2018, Volume 3

DOI: 10.21767/2572-5432-C1-002